-
Mashup Score: 2
During an OncLive Peer Exchange, a panel of expert clinicians in CRC discussed studies seeking to further define the role of MRD testing in CRC.
Source: www.onclive.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
The European Medicines Agency has validated an application for nivolumab plus ipilimumab for frontline MSI-H/dMMR metastatic colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11
The European Medicines Agency has validated an application for nivolumab plus ipilimumab for frontline MSI-H/dMMR metastatic colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study - 13 day(s) ago
AbstractBackground. Small bowel adenocarcinoma is a rare cancer, and the role of adjuvant chemotherapy for localized disease is still debated.Methods. This
Source: academic.oup.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FRESCO-2 Study Design Overview - 15 day(s) ago
Medical professionals provide background on the FRESCO-2 trial, which compared Fruquintinib to placebo in patients with heavily pretreated metastatic colorectal cancer. The trial enrolled patients who had exhausted all standard treatment options, including cytotoxic chemotherapy, targeted therapies, anti-VEGF agents, and BRAF inhibitors for those with BRAF mutations.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Retrospective Data Demonstrates Efficacy of Regorafenib in mCRC - 24 day(s) ago
During a Case-Based Roundtable® event, Madappa Kundranda, MD, PhD, discussed recent retrospective studies that compared outcomes between the available treatment options in patients with relapsed/refractory advanced colorectal cancer in the first article of a 2-part series.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
A phase 2/3 study of GRANITE vaccine in combination with standard therapy shows encouraging early signs of efficacy and safety in patients with metastatic microsatellite-stable colorectal cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0A2B530 Receives FDA Orphan Drug Designation in CRC - 2 month(s) ago
The FDA has granted orphan drug designation to A2B530 for the treatment of select patients with colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Colorectal Cancer: Leveraging Awareness and Early Detection - 2 month(s) ago
For Colorectal Cancer Awareness Month, Jedrzej Wykretowicz, MD, PhD, discussed the importance of early detection and taking steps towards the prevention of colorectal cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0A2B530 Receives FDA Orphan Drug Designation in CRC - 2 month(s) ago
The FDA has granted orphan drug designation to A2B530 for the treatment of select patients with colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
RT @OncLive: Advances in MRD Testing Help Guide Optimal Colorectal Cancer Therapy @benweinbergmd @marshalj23 #crcsm https://t.co/gDRU48b707